Optimizing a Bayesian hierarchical adaptive platform trial design for stroke patients

BACKGROUND: Platform trials are well-known for their ability to investigate multiple arms on heterogeneous patient populations and their flexibility to add/drop treatment arms due to efficacy/lack of efficacy. Because of their complexity, it is important to develop highly optimized, transparent, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Guangyi, Gajewski, Byron J., Wick, Jo, Beall, Jonathan, Saver, Jeffrey L., Meinzer, Caitlyn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Methodology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446515/
https://www.ncbi.nlm.nih.gov/pubmed/36068547
http://dx.doi.org/10.1186/s13063-022-06664-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446515/
https://www.ncbi.nlm.nih.gov/pubmed/36068547
http://dx.doi.org/10.1186/s13063-022-06664-4

Ejemplares similares